OSIA
WST icon

O'Shares Investment Advisers’s West Pharmaceutical WST Stock Holding History

O'Shares Investment Advisers’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-8,638
Closed -$1.96M – 344
2020
Q2 		$1.96M Buy
+8,638
New +$1.7M 0.25% 103

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

O'Shares Investment Advisers's WST Position: Q3 2020 in Review

O'Shares Investment Advisers sold out of West Pharmaceutical (WST) in Q3 2020, closing a stake of 8,638 shares — an estimated $1.96M sold.

O'Shares Investment Advisers first reported a position in WST in Q2 2020 and held it in 1 quarter. The position peaked at $1.96M in Q2 2020. 573 funds tracked by Wall St. Rank hold WST as of Q3 2020.

  • O'Shares Investment Advisers reported no remaining West Pharmaceutical position as of Q3 2020 after selling out during the quarter.
  • O'Shares Investment Advisers sold 8,638 West Pharmaceutical shares in Q3 2020, an estimated $1.96M.
  • O'Shares Investment Advisers first reported a position in West Pharmaceutical in Q2 2020 and held it in 1 quarter.
  • O'Shares Investment Advisers's West Pharmaceutical position peaked at $1.96M in Q2 2020.
  • 573 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2020.

Based on O'Shares Investment Advisers's 13F filing for Q3 2020, filed 12 Nov 2020.